Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of €1.15 million as of April 28, 2026. Its market cap has decreased by -97.67% in one year.

Market Cap

1.15M

Enterprise Value

20.43M

Revenue

55.42M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.00

Market Cap Chart

Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 1.15M, a decrease of -99.89%. That is a compound annual growth rate of -46.39%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	1.15M	-80.37%
Dec 31, 2025	5.87M	-95.59%
Dec 31, 2024	133.14M	-18.29%
Dec 29, 2023	162.94M	-27.20%
Dec 30, 2022	223.81M	-56.55%
Dec 31, 2021	515.06M	-24.48%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
co.don AG	374.13K
Paion AG	317.45K
bioXXmed AG	246.04K
MagForce AG	183.44K
Biomark Diagnostics	36.57M
2invest AG	48.04M
Darwin AG	92.40M
Biotest Aktiengesellschaft	1.46B

Market Cap Rankings